| dc.contributor |
Europol |
|
| dc.contributor |
European Monitoring Centre for Drugs and Drug Addiction |
|
| dc.date.accessioned |
2019-04-08T10:17:34Z |
|
| dc.date.available |
2019-04-08T10:17:34Z |
|
| dc.date.issued |
2007 |
|
| dc.identifier.other |
1700155415 |
de_DE |
| dc.identifier.uri |
http://hdl.handle.net/10900/87569 |
|
| dc.identifier.uri |
http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-875690 |
de_DE |
| dc.identifier.uri |
http://dx.doi.org/10.15496/publikation-28955 |
|
| dc.description.abstract |
In December 2006, after examining the available information collected on BZP (1-benzylpiperazine), the EMCDDA and Europol decided to launch a procedure for the production of a Joint Report. Pursuant to the findings of this report, the Council of the EU formally requested a risk assessment of the substance, which was submitted to control measures and criminal penalties throughout the European Union in March 2008. |
en |
| dc.language.iso |
en |
de_DE |
| dc.publisher |
Universität Tübingen |
de_DE |
| dc.publisher |
Universität Tübingen |
de_DE |
| dc.subject.classification |
Droge , Drogenmissbrauch , Europäische Union |
de_DE |
| dc.subject.ddc |
360 |
de_DE |
| dc.title |
Europol–EMCDDA Joint Report on a new psychoactive substance: 1-benzylpiperazine (BZP) |
en |
| dc.title |
In accordance with Article 5 of Council Decision 2005/387/JHA on information exchange, risk assessment and control of new psychoactive substances |
en |
| dc.type |
Report |
de_DE |
| utue.publikation.fachbereich |
Kriminologie |
de_DE |
| utue.publikation.fakultaet |
Kriminologisches Repository |
de_DE |
| utue.opus.portal |
kdoku |
de_DE |
